Tocilizumab reduces cardiac injury after out-of-hospital cardiac arrest primarily in patients without acute revascularization - Results from a randomized trial, The IMICA trial

13 March 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Live Abstract session - Cardiopulmonary resuscitation Cardiac Arrest ACVC Premium Access ACVC 2021

ESC 365 is supported by

ESC 365 is supported by